trial
as of 2026-07-01Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
NCTId NCT01423916
at a glance
Phase 1 · Completed
Enrollment 218 (actual)
Primary completion 2012-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
218 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2011-07
Primary completion
2012-02
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Sites
8 total
Long Beach, United StatesSan Diego, United StatesFort Lauderdale, United StatesOverland Park, United StatesRockville, United StatesSt Louis, United StatesPhiladelphia, United StatesAustin, United States
Facts & assertions
4 sourced
Enrollment
218
Phase
PHASE1
Primary Completion Date
2012-02
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication